Nearly 2,000 mortgage lenders are using Equifax's VantageScore 4.0 credit scoring model, which incorporates alternative data like rental and utility payments, to improve borrower evaluation and expand credit access. Equifax has extended the $1 pricing for this score through 2028 to encourage wider adoption, potentially saving the industry $1 billion in costs. This move follows approval by the Federal Housing Finance Agency for use in Fannie Mae and Freddie Mac loans, signaling a shift toward more inclusive and cost-effective mortgage lending. Equifax also offers additional data tools at no extra cost to support lenders in making better decisions and enhancing homeownership affordability.
Equifax's VantageScore 4.0 adoption in mortgage lending is part of a broader financial market landscape where, as of Oct 09, 2026 03:11 WIB, 69 of 118 Financials-sector US stocks tradable on Pluang rose while 48 fell. Notable price changes include Hut 8 Corp at USD 79.70 with a -10.75% change and a typical hold time of 11 days, Riot Platforms Inc at USD 16.88 with a -8.95% change and a 16-day hold time, and CleanSpark Inc at USD 10.62 with a -7.81% change and a 21-day hold time. Pluang order activity shows strong buying interest in Hut 8 Corp and CleanSpark Inc at 89% and 97% buy respectively.
Pacira BioSciences was downgraded from Buy to Hold by Needham following Viatris's announcement to acquire the company for $36.50 per share, valuing it at about $1.65 billion. The deal is expected to close by late 2026 and will enhance Viatris's portf...
Equifax has introduced Mortgage Score Select, a new tool allowing mortgage lenders and brokers to choose which credit score to include on a mortgage credit file or to pull the file without a score. This innovation offers cost savings by enabling a se...
Ashish Kumar, former AI lead for Tesla's humanoid robot Optimus, has founded Intelligent Machines, a startup focused on building task-specific industrial robots rather than humanoid ones. The company uses reinforcement learning to train robots for sp...
argenx SE (ARGX) shares fell over 10% on October 8, 2026, after the company stopped its Phase 3 UNITY trial of subcutaneous Vyvgart for Sjögren's disease due to futility. An independent committee found the study unlikely to meet its primary endpoint,...
Virtus Convertible & Income Fund II (NCZ) and Virtus Convertible & Income Fund (NCV) hold nearly identical portfolios but trade at significantly different discounts to NAV, with NCZ at a 9.51% discount and NCV at a 12.13% discount. This gap is about ...
